Subscribe
shutterstock_1179311575_vchal
Vchal / Shutterstock.com
9 April 2020AmericasSarah Morgan

Merck KGaA secures second US CRISPR patent

Millipore Sigma, the US life sciences business of  Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.
Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Americas
Merck expands CRISPR patent portfolio
12 May 2020   Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Merck expands CRISPR patent portfolio
12 May 2020   Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.
Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

More on this story

Americas
Merck expands CRISPR patent portfolio
12 May 2020   Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.
Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug